Genmab A/S (GNMSF) Operating income 2023–2025
Genmab A/S (GNMSF) annual operating income history from SEC filings — each fiscal year as reported.
$1.1BFY2025 · since FY2023: $772.0M → $1.1B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.1B | +9.6% |
| FY2024 | $972.0M | +25.9% |
| FY2023 | $772.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More GNMSF financial trends
GNMSF RevenueGNMSF Net incomeGNMSF Net marginGNMSF Gross profitGNMSF Gross marginGNMSF Operating marginGNMSF Operating cash flowGNMSF Free cash flowGNMSF Capital expendituresGNMSF Return on equityGNMSF Stock buybacksGNMSF Dividends paidGNMSF Total assetsGNMSF Total liabilitiesGNMSF Shareholders’ equityGNMSF overview →